androgen independent prostate cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data suggest that NEU3 regulates tumor progression through AR signaling, and thus be a potential tool for diagnosis and therapy of androgen-independent prostate cancer.
|
21681193 |
2012 |
Progression of prostate cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling.
|
21681193 |
2012 |
melanoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
All these results suggest that NEU3 is highly expressed to enhance malignant phenotypes including apoptosis inhibition in malignant melanomas.
|
21895867 |
2011 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Taken together, the present findings suggest that Neu3 is a promising molecular target for the prevention of prostate cancer metastasis.
|
22093819 |
2011 |
Secondary malignant neoplasm of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mice treated with attenuated Salmonella carrying the Neu3 siRNA developed fewer bone metastases than mice treated with attenuated Salmonella carrying a control Scramble siRNA, attenuated Salmonella alone or PBS.
|
22093819 |
2011 |
Acute lymphocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Consequently, Neu3 could represent a new potent biomarker in childhood ALL, to assess the efficacy of therapeutic protocols and to rapidly identify an eventual relapse.
|
19588508 |
2010 |
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Consequently, Neu3 could represent a new potent biomarker in childhood ALL, to assess the efficacy of therapeutic protocols and to rapidly identify an eventual relapse.
|
19588508 |
2010 |
Adult Acute Lymphocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Consequently, Neu3 could represent a new potent biomarker in childhood ALL, to assess the efficacy of therapeutic protocols and to rapidly identify an eventual relapse.
|
19588508 |
2010 |
Carcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
NEU3 is markedly up-regulated in many types of cancers including colon and renal carcinomas and suppresses apoptosis of cancer cells.
|
18023981 |
2008 |
Adenocarcinoma, Clear Cell
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.
|
17476974 |
2006 |
Ovarian adenocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.
|
17476974 |
2006 |
Clear cell adenocarcinoma of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study aimed to investigate sialidase expression of ovarian cancer cells and to evaluate the relationship between plasma membrane-associated sialidase (NEU3) expression and various clinicopathological factors in ovarian clear cell adenocarcinoma patients.
|
17476974 |
2006 |
Colonic Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.
|
12149448 |
2002 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.
|
12149448 |
2002 |